A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia

(2014) I. C. Macdougall et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)

(2013) Walter Reinisch et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Notice

(2012)   Kidney International Supplements

Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease

(2011) Björn Wikström et al.   JOURNAL OF NEPHROLOGY

A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients

(2010) Wajeh Y. Qunibi et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Ferumoxytol for Treating Iron Deficiency Anemia in CKD

(2008) B. S. Spinowitz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY